Cargando…
In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies
Background: We assumed that the pharmacokinetics of lovastatin could be changed by the induction effect of berberine. Methods: An UPLC-MS/MS method was developed and validated for the pharmacokinetics tudy of lovastatin to investigate the in vivo drug-drug interactions between lovastatin and berberi...
Autores principales: | Cui, Hanming, Wang, Jialong, Zhang, Qiuyan, Dang, Mengmeng, Liu, Hui, Dong, Yu, Zhang, Lu, Yang, Fang, Wu, Jianhua, Tong, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272956/ https://www.ncbi.nlm.nih.gov/pubmed/27070564 http://dx.doi.org/10.3390/molecules21040464 |
Ejemplares similares
-
Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells
por: Nasiri, Marjan, et al.
Publicado: (2016) -
Encapsulation of Lovastatin in Zein Nanoparticles Exhibits Enhanced Apoptotic Activity in HepG2 Cells
por: Alhakamy, Nabil A., et al.
Publicado: (2019) -
Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation
por: Yu, Rong, et al.
Publicado: (2014) -
Mitochondrial membrane potential played crucial roles in the accumulation of berberine in HepG2 cells
por: Li, Qiao, et al.
Publicado: (2019) -
Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB
por: Li, Min, et al.
Publicado: (2017)